BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 9661001)

  • 1. Antiherpesvirus activities of (1'S,2'R)-9-[[1',2'-bis(hydroxymethyl)cycloprop-1'-yl]methyl]guanine (A-5021) in cell culture.
    Iwayama S; Ono N; Ohmura Y; Suzuki K; Aoki M; Nakazawa H; Oikawa M; Kato T; Okunishi M; Nishiyama Y; Yamanishi K
    Antimicrob Agents Chemother; 1998 Jul; 42(7):1666-70. PubMed ID: 9661001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mode of action of (1'S,2'R)-9-[[1',2'-bis(hydroxymethyl) cycloprop-1'-yl]methyl]guanine (A-5021) against herpes simplex virus type 1 and type 2 and varicella-zoster virus.
    Ono N; Iwayama S; Suzuki K; Sekiyama T; Nakazawa H; Tsuji T; Okunishi M; Daikoku T; Nishiyama Y
    Antimicrob Agents Chemother; 1998 Aug; 42(8):2095-102. PubMed ID: 9687413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of anti-herpesvirus activity of (1'S,2'R)-9-[[1',2'-bis(hydroxymethyl)cycloprop-1'-yl]methyl]- guanine (A-5021) in mice.
    Iwayama S; Ohmura Y; Suzuki K; Ono N; Nakazawa H; Aoki M; Tanabe I; Sekiyama T; Tsuji T; Okunishi M; Yamanishi K; Nishiyama Y
    Antiviral Res; 1999 Jun; 42(2):139-48. PubMed ID: 10389656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and antiviral activity of novel acyclic nucleosides: discovery of a cyclopropyl nucleoside with potent inhibitory activity against herpesviruses.
    Sekiyama T; Hatsuya S; Tanaka Y; Uchiyama M; Ono N; Iwayama S; Oikawa M; Suzuki K; Okunishi M; Tsuji T
    J Med Chem; 1998 Apr; 41(8):1284-98. PubMed ID: 9548818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-herpesvirus activity of (1'S,2'R)-9-[[1',2'-bis(hydroxymethyl)-cycloprop-1'-yl]methyl] x guanine (A-5021) in vitro and in vivo.
    Neyts J; Naesens L; Ying C; De Bolle L; De Clercq E
    Antiviral Res; 2001 Feb; 49(2):115-20. PubMed ID: 11248363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiherpesvirus activity of 9-(4-hydroxy-3-hydroxy-methylbut-1-yl)guanine (BRL 39123) in cell culture.
    Boyd MR; Bacon TH; Sutton D; Cole M
    Antimicrob Agents Chemother; 1987 Aug; 31(8):1238-42. PubMed ID: 3631945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The anti-herpesvirus activity of (1'S,2'R)-9-[[1',2'-bis(hydroxymethyl)-cycloprop-1'-yl]methyl]guanine is markedly potentiated by the immunosuppressive agent mycophenolate mofetil.
    Neyts J; De Clercq E
    Antiviral Res; 2001 Feb; 49(2):121-7. PubMed ID: 11248364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of a DNA probe assay with the plaque reduction assay for measuring the sensitivity of herpes simplex virus and varicella-zoster virus to penciclovir and acyclovir.
    Standring-Cox R; Bacon TH; Howard BA
    J Virol Methods; 1996 Jan; 56(1):3-11. PubMed ID: 8690764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and antiviral activity of novel anti-VZV 5-substituted uracil nucleosides with a cyclopropane sugar moiety.
    Onishi T; Mukai C; Nakagawa R; Sekiyama T; Aoki M; Suzuki K; Nakazawa H; Ono N; Ohmura Y; Iwayama S; Okunishi M; Tsuji T
    J Med Chem; 2000 Jan; 43(2):278-82. PubMed ID: 10649983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mode of antiviral action of penciclovir in MRC-5 cells infected with herpes simplex virus type 1 (HSV-1), HSV-2, and varicella-zoster virus.
    Earnshaw DL; Bacon TH; Darlison SJ; Edmonds K; Perkins RM; Vere Hodge RA
    Antimicrob Agents Chemother; 1992 Dec; 36(12):2747-57. PubMed ID: 1336346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and anti-VZV activity of 6-heteroaryl derivatives of tricyclic acyclovir and 9-{[cis-1',2'-bis(hydroxymethyl)cycloprop-1'-yl]methyl}guanine analogues.
    Ostrowski T; Golankiewicz B; De Clercq E; Andrei G; Snoeck R
    Eur J Med Chem; 2009 Aug; 44(8):3313-7. PubMed ID: 19339082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the antiviral activity of (1'S,2'R)-9-[[1',2'-bis(hydroxymethyl)cycloprop-1'-yl]methyl]guanine (A-5021) against equine herpesvirus type 1 in cell monolayers and equine nasal mucosal explants.
    Glorieux S; Vandekerckhove AP; Goris N; Yang XY; Steukers L; Van de Walle GR; Croubels S; Neyts J; Nauwynck HJ
    Antiviral Res; 2012 Feb; 93(2):234-238. PubMed ID: 22178244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Susceptibilities of herpes simplex viruses to penciclovir and acyclovir in eight cell lines.
    Leary JJ; Wittrock R; Sarisky RT; Weinberg A; Levin MJ
    Antimicrob Agents Chemother; 2002 Mar; 46(3):762-8. PubMed ID: 11850259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The antiherpesvirus activity of H2G [(R)-9-[4-hydroxy-2-(hydroxymethyl)butyl]guanine] is markedly enhanced by the novel immunosuppressive agent mycophenolate mofetil.
    Neyts J; Andrei G; De Clercq E
    Antimicrob Agents Chemother; 1998 Dec; 42(12):3285-9. PubMed ID: 9835529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mode of action of (R)-9-[4-hydroxy-2-(hydroxymethyl)butyl]guanine against herpesviruses.
    Lowe DM; Alderton WK; Ellis MR; Parmar V; Miller WH; Roberts GB; Fyfe JA; Gaillard R; Ertl P; Snowden W
    Antimicrob Agents Chemother; 1995 Aug; 39(8):1802-8. PubMed ID: 7486922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of acyclovir, oxetanocin-G, and carbocyclic oxetanocin-G in combinations on the replications of herpes simplex virus type 1 and type 2 in Vero cells.
    Saijo M; Suzutani T; Yoshida I
    Tohoku J Exp Med; 1992 May; 167(1):57-68. PubMed ID: 1333651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitory action of acyclovir (ACV) and penciclovir (PCV) on plaque formation and partial cross-resistance of ACV-resistant varicella-zoster virus to PCV.
    Hasegawa T; Kurokawa M; Yukawa TA; Horii M; Shiraki K
    Antiviral Res; 1995 Jun; 27(3):271-9. PubMed ID: 8540749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sensitivity of herpes virus isolates from acyclovir clinical trials.
    Collins P; Appleyard G; Oliver NM
    Am J Med; 1982 Jul; 73(1A):380-2. PubMed ID: 6285727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of herpes simplex viruses selected in culture for resistance to penciclovir or acyclovir.
    Sarisky RT; Quail MR; Clark PE; Nguyen TT; Halsey WS; Wittrock RJ; O'Leary Bartus J; Van Horn MM; Sathe GM; Van Horn S; Kelly MD; Bacon TH; Leary JJ
    J Virol; 2001 Feb; 75(4):1761-9. PubMed ID: 11160674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The novel immunosuppressive agent mycophenolate mofetil markedly potentiates the antiherpesvirus activities of acyclovir, ganciclovir, and penciclovir in vitro and in vivo.
    Neyts J; Andrei G; De Clercq E
    Antimicrob Agents Chemother; 1998 Feb; 42(2):216-22. PubMed ID: 9527762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.